Rapid Micro Biosystems, Inc. (RPID) stock

RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3056% below fair value

$0.67−0.08 (-10.19%)

Close on Nov 12, 2026Market cap $33.66MP/E –Yield –

Rapid Micro Biosystems gross margin

Gross margin is gross profit as a percentage of revenue.

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2026	Jun 30, 2026	15.0%	–
Q1 FY2026	Mar 31, 2026	4.6%	–
Q2 FY2025	Jun 30, 2025	3.8%	–
Q1 FY2025	Mar 31, 2025	5.6%	–

Parsed from the XBRL in Rapid Micro Biosystems's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RPID.

Revenue growth16.1% · median 8.2%

Operating margin-141.5% · median -42.7%

Net margin-145.6% · median -36.9%

Advertisement
300 × 250

See a number that looks wrong?